Skip to main content
No. of Recommendations: 4
NBIX has a binary event on their latest phase II with elagolix coming up no later then May 2010. If the trial results demonstrate non-menstrual pain relief is significant (validating management's claim that the prior patient population was simply not sick enough to show any statistically significant improvement on this one measure - and there is a good chance they are correct) then from this current marketcap a triple or quadruple are quite possible.

It is a flyer, because if elagolix goes down, NBIX is worth not very much. Sure, they have a pipeline and a long history of raising money, but the only thing they have to really fall back on at this time is urocortin which is a promising phase II drug, but still quite early in its development. They can probably survive long enough however to partner it in some reasonable fashion if elagolix falls.

Tinker
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.